Real‐World Guselkumab Response and Drug Survival in Australian Patients With Psoriasis: Results From the Australasian Psoriasis Registry

Documenti analoghi

• Drug Survival of Biological Therapies in Smokers and Non‐Smokers With Psoriasis: A Retrospective Cohort Study Using Data From the Australasian Psoriasis Registry
  di: Ferial May, et al.
  Pubblicazione: (2025)
• Effectiveness of Biologics on Preventing the Development of Psoriatic Arthritis in Psoriasis Patients: A Systematic Review
  di: Kathleen L. Miao, et al.
  Pubblicazione: (2026)
• Differential Effects of Biologics and Small‐Molecule Drugs on Metabolic and Inflammatory Markers in Psoriasis: A Network Meta‐Analysis Implications for Comorbidity‐Driven Drug Selection
  di: Han-Ying Tian, et al.
  Pubblicazione: (2026)
• Eczematous Eruption on Hands and Feet After Treatment With Biological Agents for Psoriasis
  di: Fen Peng, et al.
  Pubblicazione: (2025)
• Real‐World Experience of Secukinumab Treatment in Patients with Moderate‐to‐Severe Plaque Psoriasis in Greece: 3‐Year Interim Results of the SERENA Study
  di: Dimitrios Ioannides, et al.
  Pubblicazione: (2024)